Moderate hypofractionated post-prostatectomy radiation therapy is feasible and well tolerated: experience from a single tertiary cancer centre.

J ValeroAngel MonteroO HernandoM IzquierdoE SánchezM García-ArandaM LópezR CiérvideJ MartíB ÁlvarezR AlonsoX Chen-ZhaoP Fernández-LetónC Rubio

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2021)

Hypofractionated radiotherapy (62.5 Gy in 25 2.5 Gy fractions) is feasible and well tolerated with low complication rates allowing for a moderate dose-escalation that offers encouraging clinical results for biochemical control and survival in patients with prostate cancer after radical prostatectomy.

Keyphrases

radiation therapy
radical prostatectomy
prostate cancer
locally advanced
radiation induced
high intensity
papillary thyroid
squamous cell
robot assisted
early stage
squamous cell carcinoma
clinical trial
benign prostatic hyperplasia
young adults
study protocol